Oslo, 5 July 2021. Reference is made to the stock exchange announcement by
Nordhealth AS (the "Company") on 3 July 2021 regarding completion of the
stabilization period.

As part of completion of the stabilization period, Carnegie AS (the "Manager")
purchased from and redelivered shares to the lending shareholders. The following
shares were purchased from and redelivered to primary insiders of the Company
and their close associates:

1,417,475 shares were sold at a price of NOK 40.786 per share and 1,769,275
shares were redelivered to Three Plus Group S.A. Three Plus Group S.A. is a
close associate of the CEO, Charles MacBain. Following purchase and redelivery
of the shares, Three Plus Group S.A. owns 4,956,027 class A shares and
29,742,998 class B shares in the Company, equal to approximately 46.27% of the
outstanding existing shares.

19,197 shares were sold at a price of NOK 40.786 per share and 23,960 shares
were redelivered to Oy Pasanen & Co. Oy Pasanen & Co is a close associate of the
CFO, Valter Pasanen. Following purchase and redelivery of the shares, Oy Pasanen
& Co owns 67,116 class A shares and 402,796 class B shares in the Company, equal
to approximately 0.63% of the outstanding existing shares.

129,780 shares were sold at a price of NOK 40.786 per share and 161,989 shares
were redelivered to Janne Huttunen. Following purchase and redelivery of the
shares, Janne Huttunen owns 453,757 class A shares and 2,723,175 class B shares
in the Company, equal to approximately 4.24% of the outstanding existing shares.

34,454 shares were sold at a price of NOK 40.786 per share and 43,006 shares
were redelivered to Olli Venemies. Following purchase and redelivery of the
shares, Olli Venemies owns 120,468 class A shares and 722,967 class B shares in
the Company, equal to approximately 1.13% of the outstanding existing shares.

34,455 shares were sold at a price of NOK 40.786 per share and 43,006 shares
were redelivered to Juha Huttunen. Following purchase and redelivery of the
shares, Juha Huttunen owns 120,467 class A shares and 722,966 class B shares in
the Company, equal to approximately 1.13% of the outstanding existing shares.

Please refer to the attached notifications of trading for further details.

For further information, please contact:

Charles MacBain, CEO charles.macbain@nordhealth.com +44 75 3903 2200

Valter Pasanen, CFO valter.pasanen@nordhealth.com +358 50 560 9286

About Nordhealth

Nordhealth is a cloud-based healthcare SaaS company whose mission is to redefine
digital healthcare. The Company's products empower healthcare professionals to
improve patient care, increase efficiency and expand their business. Since 2005,
the Company has acquired and built cloud-based software for veterinary and
therapeutic professionals and their patients, and now serves more than 30,000
professionals across 7,000 clinics and hospitals located in over 25 countries.


Headquartered in Espoo, Finland, Nordhealth has a solid footprint in the Nordic
region and a growing presence internationally, with more than 240 employees
working either remotely or from offices (collaboration hubs), serving a global
customer base. Visit the company's website at
nordhealth.comÂ (http://www.nordhealth.com).